Search results for abx831229

Pateclizumab, Abbexa, abx831229

Pateclizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting LTA/TNFSF1, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Pateclizumab is under investigation in clinical trial NCT01225393 (A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis).